Cobimetinib ( DrugBank: Cobimetinib )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 280 | 巨大動静脈奇形（頚部顔面又は四肢病変） | 1 |
280. 巨大動静脈奇形（頚部顔面又は四肢病変）
臨床試験数 : 27 / 薬物数 : 30 - (DrugBank : 15) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 153
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05125471 (ClinicalTrials.gov) | July 26, 2022 | 12/11/2021 | Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study) | COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arteriovenous Malformations (AVM) | Arteriovenous Malformations (Extracranial) | Drug: Cobimetinib | University of Arkansas | Genentech, Inc. | Recruiting | 2 Years | 80 Years | All | 17 | Phase 2 | United States |